FastGlioma is a new technology powered by AI that can, within seconds, determine during surgery if any part of a cancerous brain tumor that could be removed remains. Todd Hollon, M.D., a neurosurgeon at U-M Health and assistant professor of neurosurgery at U-M Medical School, discusses this exciting new technology and AI’s future in cancer.
